BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16103080)

  • 1. Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.
    Shalom-Feuerstein R; Cooks T; Raz A; Kloog Y
    Cancer Res; 2005 Aug; 65(16):7292-300. PubMed ID: 16103080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
    Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation.
    Paz A; Haklai R; Elad-Sfadia G; Ballan E; Kloog Y
    Oncogene; 2001 Nov; 20(51):7486-93. PubMed ID: 11709720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer.
    Fukumori T; Oka N; Takenaka Y; Nangia-Makker P; Elsamman E; Kasai T; Shono M; Kanayama HO; Ellerhorst J; Lotan R; Raz A
    Cancer Res; 2006 Mar; 66(6):3114-9. PubMed ID: 16540661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the nuclear import pathways of galectin-3.
    Nakahara S; Oka N; Wang Y; Hogan V; Inohara H; Raz A
    Cancer Res; 2006 Oct; 66(20):9995-10006. PubMed ID: 17047062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells.
    Rubio I; Rennert K; Wittig U; Beer K; Dürst M; Stang SL; Stone J; Wetzker R
    Biochem J; 2006 Sep; 398(2):243-56. PubMed ID: 16709153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.
    Pervin S; Singh R; Hernandez E; Wu G; Chaudhuri G
    Cancer Res; 2007 Jan; 67(1):289-99. PubMed ID: 17210710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase.
    Scuto A; Zhang H; Zhao H; Rivera M; Yeatman TJ; Jove R; Torres-Roca JF
    Cancer Res; 2007 Nov; 67(21):10317-24. PubMed ID: 17974974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells.
    Sun P; Watanabe H; Takano K; Yokoyama T; Fujisawa J; Endo T
    Genes Cells; 2006 Sep; 11(9):1097-113. PubMed ID: 16923128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.
    Dreissigacker U; Mueller MS; Unger M; Siegert P; Genze F; Gierschik P; Giehl K
    Cell Signal; 2006 Aug; 18(8):1156-68. PubMed ID: 16257181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
    Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
    Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway.
    Li TS; Li XN; Chang ZJ; Fu XY; Liu L
    Cell Signal; 2006 Aug; 18(8):1287-98. PubMed ID: 16310341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
    Kogut MH; Genovese KJ; He H
    Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
    Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
    Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3.
    Shalom-Feuerstein R; Plowman SJ; Rotblat B; Ariotti N; Tian T; Hancock JF; Kloog Y
    Cancer Res; 2008 Aug; 68(16):6608-16. PubMed ID: 18701484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity.
    Elad-Sfadia G; Haklai R; Balan E; Kloog Y
    J Biol Chem; 2004 Aug; 279(33):34922-30. PubMed ID: 15205467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.